Evaluation of Myocardial Iron Overload Using Magnetic Resonance Imaging

Overview

Journal Blood Transfus

Specialty Hematology

Date 2009 Aug 7

PMID 19657481

Citations 4

Authors

Sophie Mavrogeni

Affiliations

Soon will be listed here.

Citing Articles

Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 1: Common phenotypes.

McDermott S, ONeill A, Ridge C, Dodd J World J Cardiol. 2012; 4(4):103-11.

PMID: 22558489 PMC: 3342578. DOI: 10.4330/wjc.v4.i4.103.

Comparison of myocardial and hepatic iron loading, assessed by MRI T2*, in patients with myelodysplastic syndromes, thalassaemia major and controls.

Mavrogeni S Blood Transfus. 2012; 10(2):237-40.

PMID: 22244006 PMC: 3320790. DOI: 10.2450/2011.0084-11.

Evaluation of myocardial and hepatic iron loading by MRI T2* in multi-transfused patients with repeated blood loss as compared to thalassaemia major patients and controls.

Mavrogeni S Blood Transfus. 2011; 9(3):343-5.

PMID: 21627929 PMC: 3136605. DOI: 10.2450/2011.0099-10.

Future challenges in the use of magnetic resonance imaging for the diagnosis of iron overload.

Kolnagou A, Kontoghiorghes G Blood Transfus. 2010; 8(4):309-10.

PMID: 20967176 PMC: 2957500. DOI: 10.2450/2010.0017-10.

References

Sonakul D, Thakerngpol K, PACHAREE P . Cardiac pathology in 76 thalassemic patients. Birth Defects Orig Artic Ser. 1988; 23(5B):177-91. View

Gomori J, Grossman R, Drott H . MR relaxation times and iron content of thalassemic spleens: an in vitro study. AJR Am J Roentgenol. 1988; 150(3):567-9. DOI: 10.2214/ajr.150.3.567. View

Westwood M, Anderson L, Firmin D, Gatehouse P, Lorenz C, Wonke B . Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging. 2003; 18(5):616-20. DOI: 10.1002/jmri.10396. View

Brasch R, Wesbey G, Gooding C, Koerper M . Magnetic resonance imaging of transfusional hemosiderosis complicating thalassemia major. Radiology. 1984; 150(3):767-71. DOI: 10.1148/radiology.150.3.6695078. View

Anderson L, Holden S, Davis B, Prescott E, Charrier C, Bunce N . Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2002; 22(23):2171-9. DOI: 10.1053/euhj.2001.2822. View

Gomori J, Horev G, Tamary H, Zandback J, Kornreich L, Zaizov R . Hepatic iron overload: quantitative MR imaging. Radiology. 1991; 179(2):367-9. DOI: 10.1148/radiology.179.2.2014276. View

Kolnagou A, Kontoghiorghes G . Effective combination therapy of deferiprone and deferoxamine for the rapid clearance of excess cardiac IRON and the prevention of heart disease in thalassemia. The Protocol of the International Committee on Oral Chelators. Hemoglobin. 2006; 30(2):239-49. DOI: 10.1080/03630260600642567. View

Bernardino M, Small W, Goldstein J, Sewell C, Sones P, GALAMBOS J . Multiple NMR T2 relaxation values in human liver tissue. AJR Am J Roentgenol. 1983; 141(6):1203-8. DOI: 10.2214/ajr.141.6.1203. View

Zurlo M, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C . Survival and causes of death in thalassaemia major. Lancet. 1989; 2(8653):27-30. DOI: 10.1016/s0140-6736(89)90264-x. View

10.

Brittenham G, Farrell D, Harris J, Feldman E, Danish E, Muir W . Magnetic-susceptibility measurement of human iron stores. N Engl J Med. 1982; 307(27):1671-5. DOI: 10.1056/NEJM198212303072703. View

11.

Mavrogeni S, Markussis V, Kaklamanis L, Tsiapras D, Paraskevaidis I, Karavolias G . A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol. 2005; 75(3):241-7. DOI: 10.1111/j.1600-0609.2005.00474.x. View

12.

Vymazal J, Brooks R, Zak O, McRill C, Shen C, DI CHIRO G . T1 and T2 of ferritin at different field strengths: effect on MRI. Magn Reson Med. 1992; 27(2):368-74. DOI: 10.1002/mrm.1910270218. View

13.

Anderson L, Wonke B, Prescott E, Holden S, Walker J, Pennell D . Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet. 2002; 360(9332):516-20. DOI: 10.1016/s0140-6736(02)09740-4. View

14.

Guyader D, Gandon Y, Robert J, Heautot J, Jouanolle H, Jacquelinet C . Magnetic resonance imaging and assessment of liver iron content in genetic hemochromatosis. J Hepatol. 1992; 15(3):304-8. DOI: 10.1016/0168-8278(92)90060-3. View

15.

Tanner M, Galanello R, Dessi C, Smith G, Westwood M, Agus A . A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation. 2007; 115(14):1876-84. DOI: 10.1161/CIRCULATIONAHA.106.648790. View

16.

Tanner M, Galanello R, Dessi C, Smith G, Westwood M, Agus A . Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J Cardiovasc Magn Reson. 2008; 10:12. PMC: 2289829. DOI: 10.1186/1532-429X-10-12. View

17.

Angelucci E, Muretto P, Nicolucci A, Baronciani D, Erer B, Gaziev J . Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood. 2002; 100(1):17-21. DOI: 10.1182/blood.v100.1.17. View

18.

Pepe A, Positano V, Santarelli M, Sorrentino F, Cracolici E, De Marchi D . Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload. J Magn Reson Imaging. 2006; 23(5):662-8. DOI: 10.1002/jmri.20566. View

19.

Mavrogeni S, Gotsis E, Markussis V, Tsekos N, Politis C, Vretou E . T2 relaxation time study of iron overload in b-thalassemia. MAGMA. 1998; 6(1):7-12. DOI: 10.1007/BF02662506. View

20.

Ohene-Frempong K, Schwartz E . Clinical features of thalassemia. Pediatr Clin North Am. 1980; 27(2):403-20. DOI: 10.1016/s0031-3955(16)33858-5. View